These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1083 related items for PubMed ID: 17599414

  • 1. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.
    Chan WM, Lai TY, Liu DT, Lam DS.
    Ophthalmology; 2007 Dec; 114(12):2190-6. PubMed ID: 17599414
    [Abstract] [Full Text] [Related]

  • 2. Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results.
    Gharbiya M, Allievi F, Mazzeo L, Gabrieli CB.
    Am J Ophthalmol; 2009 Jan; 147(1):84-93.e1. PubMed ID: 18774547
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.
    Chan WM, Lai TY, Liu DT, Lam DS.
    Am J Ophthalmol; 2007 Jun; 143(6):977-983. PubMed ID: 17459318
    [Abstract] [Full Text] [Related]

  • 4. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study.
    Chan WM, Lai TY, Liu DT, Lam DS.
    Br J Ophthalmol; 2009 Feb; 93(2):150-4. PubMed ID: 18801766
    [Abstract] [Full Text] [Related]

  • 5. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series.
    Iacono P, Parodi MB, Papayannis A, Kontadakis S, Sheth S, Bandello F.
    Retina; 2011 Oct; 31(9):1841-7. PubMed ID: 21775926
    [Abstract] [Full Text] [Related]

  • 6. Intravitreous bevacizumab to treat subfoveal choroidal neovascularization in highly myopic eyes: short-term results.
    Ruiz-Moreno JM, Gomez-Ulla F, Montero JA, Ares S, Lopez-Lopez F, Rodriguez M, Fernandez M.
    Eye (Lond); 2009 Feb; 23(2):334-8. PubMed ID: 18064056
    [Abstract] [Full Text] [Related]

  • 7. Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome.
    Ruiz-Moreno JM, Montero JA, Gomez-Ulla F, Ares S.
    Br J Ophthalmol; 2009 Apr; 93(4):448-51. PubMed ID: 19091851
    [Abstract] [Full Text] [Related]

  • 8. Choroidal neovascularization in pathologic myopia: intravitreal ranibizumab versus bevacizumab--a randomized controlled trial.
    Gharbiya M, Giustolisi R, Allievi F, Fantozzi N, Mazzeo L, Scavella V, Gabrieli CB.
    Am J Ophthalmol; 2010 Mar; 149(3):458-64.e1. PubMed ID: 20172072
    [Abstract] [Full Text] [Related]

  • 9. Intravitreal ranibizumab for the primary treatment of choroidal neovascularization secondary to pathologic myopia.
    Lai TY, Chan WM, Liu DT, Lam DS.
    Retina; 2009 Jun; 29(6):750-6. PubMed ID: 19357555
    [Abstract] [Full Text] [Related]

  • 10. Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks.
    Sawa M, Gomi F, Tsujikawa M, Sakaguchi H, Tano Y.
    Am J Ophthalmol; 2009 Oct; 148(4):584-590.e2. PubMed ID: 19541288
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intravitreal bevacizumab for extrafoveal choroidal neovascularization secondary to pathologic myopia.
    Parodi MB, Iacono P, Papayannis A, Kontadakis S, Cascavilla ML, Zucchiatti I, Bandello F.
    Retina; 2013 Mar; 33(3):593-7. PubMed ID: 23190919
    [Abstract] [Full Text] [Related]

  • 17. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration.
    Bashshur ZF, Bazarbachi A, Schakal A, Haddad ZA, El Haibi CP, Noureddin BN.
    Am J Ophthalmol; 2006 Jul; 142(1):1-9. PubMed ID: 16815245
    [Abstract] [Full Text] [Related]

  • 18. Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.
    Ehrlich R, Ciulla TA, Maturi R, Kheradiya NS, Hrisomalos N, Shulman S, Guess MG, Coyle E, Harris A.
    Retina; 2009 Jul; 29(10):1418-23. PubMed ID: 19898179
    [Abstract] [Full Text] [Related]

  • 19. Intravitreal bevacizumab for treatment of myopic choroidal neovascularization: the second year of a prospective study.
    Gharbiya M, Allievi F, Conflitti S, Esposito M, Scavella V, Moramarco A, Cruciani F.
    Clin Ter; 2010 Jul; 161(3):e87-93. PubMed ID: 20589348
    [Abstract] [Full Text] [Related]

  • 20. Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy.
    Hayashi K, Ohno-Matsui K, Teramukai S, Shimada N, Moriyama M, Hayashi W, Yoshida T, Tokoro T, Mochizuki M.
    Am J Ophthalmol; 2009 Sep; 148(3):396-408. PubMed ID: 19427991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.